{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:55:05Z","timestamp":1694235305401},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Kardiatech Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.013","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T14:29:59Z","timestamp":1515767399000},"page":"1283-1287","source":"Crossref","is-referenced-by-count":6,"title":["Dipyridamole plus Triflusal versus Triflusal Alone in Infarct Reduction after Middle Cerebral Artery Occlusion"],"prefix":"10.1016","volume":"27","author":[{"given":"Zareen","family":"Amtul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasimul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Cechetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0010","first-page":"436125","article-title":"The incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: a literature review","volume":"2012","author":"Zhang","year":"2012","journal-title":"Stroke Res Treat"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000096017","article-title":"Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets","volume":"73","author":"Mitsios","year":"2006","journal-title":"Pathobiology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrn1106","article-title":"Neurological diseases: mechanisms, challenges and opportunities in stroke","volume":"4","author":"Lo","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:MEBR.0000043966.46964.e6","article-title":"Pathophysiology of stroke: lessons from animal models","volume":"19","author":"Mergenthaler","year":"2004","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1602\/neurorx.2.3.396","article-title":"Rodent models of focal stroke: size, mechanism, and purpose","volume":"2","author":"Carmichael","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0035","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2010.66","article-title":"Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia","volume":"30","author":"Howells","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF01403007","article-title":"Rat middle cerebral artery occlusion using an intraluminal thread technique","volume":"109","author":"Kawamura","year":"1991","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0045","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/01.STR.20.12.1627","article-title":"Rodent models of cerebral ischemia","volume":"20","author":"Ginsberg","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0055","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0060","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0065","series-title":"Studies in natural product chemistry","first-page":"373","article-title":"Neutraceuticals neuroprotect naturally: Alzheimer's disease, Parkinson's disease, stroke and major depressive disorder","author":"Amtul","year":"2017"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0070","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702441","article-title":"4-Trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor \u03baB activation","volume":"126","author":"Bay\u00f3n","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0080","first-page":"H2091","article-title":"Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury","volume":"277","author":"Figueredo","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1503\/cmaj.050871","article-title":"What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?","volume":"173","author":"Sudlow","year":"2005","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2010.05732.x","article-title":"Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia","volume":"1207","author":"Melani","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.eurheartj.a059456","article-title":"Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Guiteras","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0100","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.17.6.1304","article-title":"Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0105","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1460-9568.2006.04599.x","article-title":"Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats","volume":"23","author":"Burguete","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0110","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/jnnp.2008.143875","article-title":"Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk","volume":"79","author":"Halkes","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.brainres.2010.12.005","article-title":"Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia","volume":"1373","author":"Garc\u00eda-Bonilla","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0120","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1515\/revneuro-2013-0041","article-title":"Protein markers of cerebrovascular disruption of neurovascular unit: immunohistochemical and imaging approaches","volume":"25","author":"Amtul","year":"2014","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bpa.12149","article-title":"Comorbid rat model of ischemia and \u03b2-amyloid toxicity: striatal and cortical degeneration","volume":"25","author":"Amtul","year":"2015","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.neurobiolaging.2014.01.005","article-title":"Comorbid A\u03b2 toxicity and stroke: hippocampal atrophy, pathology, and cognitive deficit","volume":"35","author":"Amtul","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0135","article-title":"Hemodynamic effects of combined focal cerebral ischemia and amyloid protein toxicity in a rat model: a functional CT study","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0140","series-title":"The dynamics of BBB breakdown in a rat model of beta-amyloid toxicity and ischemia","author":"Amtul","year":"2017"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.12.013_bib0145","series-title":"The spatial cerebral damage induced by the higher dose of endothelin-1 and beta-amyloid toxicity is driven by the anatomical connectivity of CNS","author":"Amtul","year":"2018"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305717306754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305717306754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T18:50:24Z","timestamp":1535136624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305717306754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1052305717306754"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.12.013","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}